Document is current
Any future updates will be listed below
-
Authors
Matthews, Paul M. https://orcid.org/0000-0002-1619-8328
- License Information
-
More Information
Article History
Accepted: 9 July 2019
First Online: 16 August 2019
Competing interests
: P.M.M. acknowledges consultancy fees from Adelphi Communications, Biogen, Celgene and Roche. He has received honoraria or speakers’ honoraria from Biogen, Novartis and Roche, and has received research or educational funds from Biogen, GlaxoSmithKline, Nodthera and Novartis. He is a paid member of the Scientific Advisory Board for Ipsen Pharmaceuticals.
